A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Tampa FL
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07780656
Phase3, Recruiting
New
NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers
for
Advanced Small Intestine Cancer, Appendiceal Cancers
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute
Sex: All
Age: 18+
Code: NCT07060014
Phase1, Recruiting
Active & ResponsiveNew
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
for
Mild Autonomous Cortisol Secretion (MACS),
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07138274
Phase2, Recruiting
New
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
for
Prostatic Neoplasms
Location: Plymouth MA, Syracuse NY, Germantown TN, Lafayette LA
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT07832292
Phase2, Recruiting
New
DoubleTake: Effect of Message Exposure Via a Discrete Choice Experiment With Eye-Tracking on Quit Attempts Among Adults Who Smoke Menthol Cigarettes
for
Menthol Cigarettes, Smoking Behavior, Cigarette Use
Location: Atlanta GA
Sponsor: Georgia State University
Sex: All
Age: 21+
Code: NCT07782879
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial